The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners
August 29, 2024 11:48 ET
|
Global Virus Network
Last week’s meeting marked a prelude to GVN’s international meeting in Durban, South Africa, September 16-18, 2024 TAMPA, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) -- To mitigate the...
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
August 29, 2024 08:00 ET
|
Phathom Pharmaceuticals
FLORHAM PARK, N.J., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.
August 26, 2024 17:05 ET
|
Agile Therapeutics, Inc.
Agile Therapeutics has combined with Insud Pharma’s US Subsidiary, Exeltis USA, Inc., expanding an already significant women’s health/contraceptive portfolio Agile Therapeutics Common Shareholders to...
Pharmaceutical Pellets Market Opportunities Report to 2033: Competitive Landscape and Company Profiles
August 20, 2024 12:31 ET
|
Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Pellets Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.The global...
UK Patient's Perspective on the Corporate Reputation of Pharma, 2023-2024
August 20, 2024 11:52 ET
|
Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - UK Edition" report has been added to ResearchAndMarkets.com's offering. This...
Survey of 314 US Patient Groups Reveals Decline in Pharma Industry Reputation in 2023/2024
August 20, 2024 10:31 ET
|
Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups" report has been added to...
Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
August 15, 2024 09:00 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company...
Specialty Pharma Market Report 2024-2034: Specialty Pharmaceutical Market Surges in Global Spending Landscape
August 15, 2024 05:33 ET
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Specialty Pharma Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Specialty Pharma Market is set to...
AI in Drug Discovery Market: $0.9B to $4.9B Growth Forecast (2023-2028) | MarketsandMarkets™
August 14, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "AI in Drug Discovery Market Size, Share & Trends by Offering, Process (Target selection, Validation, Lead generation, optimization), Drug Design...
atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)
August 13, 2024 07:00 ET
|
atai Life Sciences
VLS-01 demonstrated a good safety and tolerability profile and a short psychedelic experience, enabling a total in-clinic treatment of two hours.